Sugi Predict

Sugi Predict / Compounds / SCHEMBL11041537

SCHEMBL11041537

SCHEMBL11041537

CCC(C)C(C)C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CA14 Q9ULX7 2/20 0.38
▸ POLB P06746 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ NOS3 P29474 2/20 0.36
▸ NOS1 P29475 2/20 0.36
▸ NOS2 P35228 2/20 0.36
▸ ZDHHC7 Q9NXF8 1/20 0.36
▸ HTT P42858 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ MMP1 P03956 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP3 P08254 1/20 0.35
▸ MME P08473 1/20 0.35
▸ ACE P12821 1/20 0.35
▸ CPA1 P15085 1/20 0.35
▸ ACE2 Q9BYF1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12890253 1.00 CA1 (0.43) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL11922731 1.00 CA1 (0.43) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL15041053 1.00 CA1 (0.43) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL13366801 1.00 CA1 (0.43) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL8223673 1.00 CA1 (0.43) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL15041052 1.00 CA1 (0.43) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL28713977 0.86 CA1 (0.41) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL17862091 0.84 SMN1; SMN2 (0.44) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL8527411 0.84 SMN1; SMN2 (0.41) CA1CA2SMN1; SMN2CA14POLB
SCHEMBL6113085 0.82 TSHR (0.38) CA1CA2ALDH1A1MAPTMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109952360-B Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device 东友精细化工有限公司 2022-03-22 — — CN disclosed
EP-2900660-B1 HERBICIDAL AND FUNGICIDAL 3-HETEROARYLISOXAZOLIN-5-CARBOXAMIDES AND 3-HETEROARYLISOXAZOLIN-5-THIOAMIDES BAYER CROPSCIENCE AG (DE) 2018-01-17 — — EP disclosed
US-20170320052-A1 COMPOSITIONS AND METHODS FOR REDUCING ATMOSPHERIC OZONE LEVELS AIR CROSS INC (US) 2017-11-09 — — US disclosed
US-9669401-B2 Compositions and methods for reducing atmospheric ozone levels AIR CROSS INC (US) 2017-06-06 — — US disclosed
EP-2900644-B1 HERBICIDAL AND FUNGICIDAL 5-OXY-SUBSTITUTED 3-PHENYLISOXAZOLIN-5-CARBOXAMIDES AND 5-OXY-SUBSTITUTED 3-PHENYLISOXAZOLIN-5-THIOAMIDES BAYER CROPSCIENCE AG (DE) 2016-09-21 — — EP disclosed
US-9309204-B2 Process for making hydroxylated cyclopentylpyrimidine compounds ARRAY BIOPHARMA INC. (US) 2016-04-12 — — US disclosed
US-20160038931-A1 COMPOSITIONS AND METHODS FOR REDUCING ATMOSPHERIC OZONE LEVELS AIR CROSS INC (US) 2016-02-11 — — US disclosed
US-20150099881-A1 PROCESS FOR MAKING HYDROXYLATED CYCLOPENTYLPYRIMIDINE COMPOUNDS GENETECH, INC. (US) 2015-04-09 — — US disclosed
US-20140235642-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2014-08-21 — — US disclosed
US-8778941-B2 TRPM8 antagonists and their use in treatments AMGEN INC. (US) 2014-07-15 — — US disclosed
US-20130158034-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2013-06-20 — — US disclosed
US-20130053342-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER L'OREAL (FR) 2013-02-28 — — US disclosed
US-8361991-B2 Hydroxylated amide skin moisturizer L'OREAL (FR) 2013-01-29 — — US disclosed
US-20100009933-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER L'OREAL (FR) 2010-01-14 — — US disclosed
US-7186500-B2 Silver halide photographic lightsensitive material FUJI PHOTO FILM CO., LTD. (JP) 2007-03-06 — — US disclosed
US-4477447-A ANTIBIOTIC, BACTERICIDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-16 — — US disclosed
US-4205013-A A RHODIUM CARBONYL COMPOUND AS CATALYST RUHRCHEMIE AKTIENGESELLSCHAFT (DE) 1980-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158034-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS TRPM8, TRPM7, TRPM5 CA1 1021/4885CA2 240/4885SMN1; SMN2 837/4885
US-20150099881-A1 PROCESS FOR MAKING HYDROXYLATED CYCLOPENTYLPYRIMIDINE COMPOUNDS PIK3CA, DHPS, PIK3CD CA1 4500/4885CA2 4380/4885SMN1; SMN2 3946/4885
US-20130053342-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER H1-0, H1-3, H1-4 CA1 1168/4885CA2 358/4885SMN1; SMN2 4819/4885
US-20140235642-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS TRPM8, TRPM7, TRPM5 CA1 1021/4885CA2 240/4885SMN1; SMN2 837/4885
US-20100009933-A1 HYDROXYLATED AMIDE SKIN MOISTURIZER H1-0, H1-3, H1-4 CA1 1399/4885CA2 424/4885SMN1; SMN2 4822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.